Text Size
48 studies found for:    Open Studies | "Warfarin"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Warfarin"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)
Condition: Warfarin Therapy
Intervention: Device: Warfarin GenoSTAT Test
2 Recruiting Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
Condition: Indications for Warfarin Therapy
Intervention: Drug: Warfarin Sodium
3 Recruiting Predictors of Anticoagulation Control on Warfarin Therapy
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Heart Valve Replacement
Intervention:
4 Recruiting Randomized Trial of Interventions to Improve Warfarin Adherence
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Dilated Cardiomyopathies
Interventions: Behavioral: Financial Incentive and Med-eMonitor;   Device: 2Med-eMonitor
5 Unknown † Clinical and Economic Implications of Genetic Testing for Warfarin Management
Condition: Blood Coagulation Disorders
Intervention: Drug: Warfarin
6 Recruiting Fiix-prothrombin Time for Monitoring Warfarin
Conditions: Thromboembolism;   Arterial;   Venous
Intervention: Device: Fiix prothrombin time
7 Not yet recruiting Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease
Conditions: Atrial Fibrillation;   Chronic Kidney Disease
Interventions: Drug: warfarin;   Drug: aspirin
8 Recruiting Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
Condition: Thromboembolism
Interventions: Other: Pharmacogenetic Warfarin Initiation;   Other: Clinical Warfarin Initiation (non-pharmacogenetic)
9 Recruiting The Study of Warfarin Maintenance Dose in Chinese Patients
Conditions: Atrial Fibrillation;   Heart Valve Disease;   Pulmonary Artery Embolism
Intervention: Drug: Warfarin
10 Unknown † VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
Conditions: Atrial Fibrillation;   Cardiac Thrombus;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Replacement (Mechanical or Biological With AF);   Cardiomyopathy (Ischemic or Dilated);   Peripheral Vascular Disease
Intervention: Drug: Warfarin dose titration
11 Not yet recruiting Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively
Condition: Primary Disease
Interventions: Drug: Dabigatran;   Drug: Warfarin
12 Recruiting Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione;   Drug: none-control group
13 Unknown † The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
Condition: Deep Venous Thromboembolism
Intervention: Drug: warfarin
14 Recruiting Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial
Condition: Anticoagulation
Interventions: Drug: warfarin;   Drug: Warfarin
15 Recruiting Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients
Condition: Advanced Solid Tumor
Interventions: Drug: LDE225;   Drug: Wafarin;   Drug: Bupropion
16 Unknown † Relationship Between Folic Acid and Warfarin Metabolism and Effect
Condition: Folic Acid Deficiency
Intervention: Drug: Folic acid
17 Not yet recruiting A Clinical Study of Lyophilized Plasma in Patients on Warfarin
Condition: Anticoagulant Therapy
Interventions: Biological: Lyophilized Plasma;   Biological: Licensed Plasma
18 Unknown † Determinants of Warfarin Metabolism
Condition: Healthy
Interventions: Drug: Warfarin;   Drug: Phenytoin
19 Unknown † Genetic Determinants of Warfarin Anticoagulation Effect
Conditions: Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation
Intervention: Drug: Warfarin
20 Unknown † Pharmacogenetic Study of Warfarin Dose-Response: a Prospective Trial
Condition: Cardiovascular Diseases
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years